Ayursundra Oncology (India) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 23-10-2024
- Paid Up Capital ₹ 0.22 M
as on 23-10-2024
- Company Age 11 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Ebitda
- Net Worth
- Total Assets 0.02%
(FY 2023)
About Ayursundra Oncology (India)
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.22 M, as per Ministry of Corporate Affairs (MCA) records.
Gautam Sarma and Abhijit Hazarika serve as directors at the Company.
- CIN/LLPIN
U85195AS2013PTC011633
- Company No.
011633
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Aug 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Company Details
- Location
Kamrup, Assam, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ayursundra Oncology (India)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gautam Sarma  | Additional Director | 20-Jun-2019 | Current |
| Abhijit Hazarika | Director | 26-Aug-2013 | Current |
Financial Performance of Ayursundra Oncology (India).
Ayursundra Oncology (India) Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Ayursundra Oncology (India)?
In 2021, Ayursundra Oncology (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ayursundra Advisors And Consultants Private LimitedActive 11 months 18 daysGautam Sarma and Abhijit Hazarika are mutual person
- Ayursundra Diagnostics Private LimitedActive 9 years 7 months
Gautam Sarma and Abhijit Hazarika are mutual person
- Ayursundra Oncology (Guwahati) Private LimitedActive 11 years 3 months
Gautam Sarma and Abhijit Hazarika are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ayursundra Oncology (India)?
Unlock and access historical data on people associated with Ayursundra Oncology (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ayursundra Oncology (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ayursundra Oncology (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
